Home / Diagnostic Instruments and Supplies / Diagnostic Accessories / Pre-Printed Label / Pre-Printed Label HCL® Advisory Label Orange / White Paper High Alert Insulins Orange Alert Label 1 X 1-3/4 Inch2090
Picture of Pre-Printed Label HCL® Advisory Label Orange / White Paper High Alert Insulins Orange Alert Label 1 X 1-3/4 Inch2090

Pre-Printed Label HCL® Advisory Label Orange / White Paper High Alert Insulins Orange Alert Label 1 X 1-3/4 Inch2090

Pre-Printed-Label-HCL®-Advisory-Label-Orange--White-Paper-High-Alert-Insulins-Orange-Alert-Label-1-X-1-3-4-Inch2090

SKU #

#1108724

MPN #

2090

Brand

Health Care Logistics

Stock

In Stock

Quantity

100

Features

LABEL, INSULIN HIGH ALERT (10/PK)

$2.10 USD

Attribute Name Attribute Value
McKesson # 1108724
Manufacturer # 2090
Brand HCL®
Manufacturer Health Care Logistics
Application Pre-Printed Label
Color Orange / White
Dimensions 1 X 1-3/4 Inch
Legend High Alert Insulins
Legend Type Alert Label
Material Paper
Script Color Orange
Type Advisory Label
UNSPSC Code 42142301

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Use to draw attention to bottles, boxes, and labels that look alike and insulins that have names that sound the same or very similar
  • Allow us to customize labels to meet your medication management needs
  • Tape and Labels help address errors caused by the use of unlabeled medications and other procedural breakdowns that can put patients at risk